Target Name: GULP1
NCBI ID: G51454
Other Name(s): OTTHUMP00000205910 | GULP1 variant 1 | CED6 | GULP, engulfment adaptor PTB domain containing 1 | CED-6 | PTB domain-containing engulfment adapter protein 1 (isoform a) | GULP | GULP1_HUMAN | Engulfment adapter protein | FLJ31156 | PTB domain adaptor protein CED-6 | cell death protein 6 homolog | GULP PTB domain containing engulfment adaptor 1, transcript variant 1 | PTB domain-containing engulfment adapter protein 1 | PTB domain adapter protein CED-6 | GULP PTB domain containing engulfment adaptor 1 | OTTHUMP00000205909 | engulfment adapter protein | OTTHUMP00000205915 | Cell death protein 6 homolog | Protein GULP

GULP1: A Potential Drug Target Or Biomarker

GULP1 (OTTHUMP00000205910) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a member of the GULP gene family, which is known for its role in the regulation of gene expression and cell signaling. GULP1 has been identified as a potential drug target or biomarker for a variety of diseases, including neurodegenerative disorders, diabetes, and liver disease.

The GULP gene family is characterized by the presence of a unique exonic splice variant, known as GULP1. This variant is associated with the development of various diseases, including neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. In addition to its association with disease, GULP1 has also been shown to play a role in the regulation of normal cellular processes, such as cell signaling and cell growth.

One of the key functions of GULP1 is its role in the regulation of gene expression. GULP1 has been shown to interact with various transcription factors, including NF-kappa-B, to regulate the expression of target genes. This interaction between GULP1 and transcription factors suggests that GULP1 may be a useful biomarker or drug target in diseases that are characterized by disruptions in gene expression.

In addition to its role in gene expression, GULP1 has also been shown to play a role in the regulation of cellular signaling pathways. GULP1 has been shown to interact with various signaling molecules, including TGF-β1, to regulate the activity of these molecules. This interaction between GULP1 and signaling molecules suggests that GULP1 may be a useful target for drugs that are designed to modulate cellular signaling pathways.

GULP1 has also been identified as a potential drug target for the treatment of neurodegenerative disorders. Neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of various symptoms. GULP1 has been shown to play a role in the regulation of the expression of genes that are involved in the development and progression of these disorders. Therefore, GULP1 may be a useful target for drugs that are designed to treat neurodegenerative disorders.

In addition to its potential use as a drug target, GULP1 has also been identified as a potential biomarker for a variety of diseases. For example, GULP1 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and levels of GULP1 have been shown to be decreased in the brains of individuals with Alzheimer's disease compared to age-matched controls. This suggests that GULP1 may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease.

In conclusion, GULP1 is a protein that has been identified as a potential drug target or biomarker for a variety of diseases. Its role in the regulation of gene expression and cellular signaling pathways suggests that GULP1 may be a useful target for drugs that are designed to modulate these processes. In addition to its potential use as a drug target, GULP1 has also been identified as a potential biomarker for a variety of diseases, including neurodegenerative disorders. Further research is needed to determine the full extent of GULP1's potential as a drug target or biomarker.

Protein Name: GULP PTB Domain Containing Engulfment Adaptor 1

Functions: May function as an adapter protein. Required for efficient phagocytosis of apoptotic cells. Modulates cellular glycosphingolipid and cholesterol transport. May play a role in the internalization and endosomal trafficking of various LRP1 ligands, such as PSAP. Increases cellular levels of GTP-bound ARF6

More Common Targets

GUSB | GUSBP1 | GUSBP11 | GUSBP12 | GUSBP14 | GUSBP15 | GUSBP17 | GUSBP2 | GUSBP3 | GUSBP4 | GUSBP5 | GUSBP8 | GVINP1 | GVQW3 | GXYLT1 | GXYLT1P3 | GXYLT1P4 | GXYLT1P6 | GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2